Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses.

AUTOR(ES)

Lettieri, J T

RESUMO

Ciprofloxacin was administered to 12 healthy male volunteers at doses of 300 and 400 mg intravenously (i.v.) and 500 and 750 mg orally in a randomized, double-blind, single-dose, four-period crossover study. On each treatment day, each subject received both oral and i.v. formulations, one of which was a placebo. Blood and urine samples were obtained through 24 h postdose. By each dosing route, the pharmacokinetic profiles were dose proportional. The 400-mg i.v. dose was equivalent to the 500-mg oral dose with respect to the area under the concentration-time curve and was equivalent to the 750-mg oral dose with respect to the maximum concentration of ciprofloxacin in serum. The oral bioavailability was 78.0%. The steady-state volume of distribution averaged 178 liters, and the terminal half-life in serum after i.v. dosing was approximately 4.3 h. Renal clearance accounted for approximately 60% of total body clearance. No significant adverse events were associated with either route of administration.

Documentos Relacionados

• Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses.
• Target Site Concentrations of Ciprofloxacin after Single Intravenous and Oral Doses
• Tissue penetration of ciprofloxacin after single and multiple doses.
• Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses.
• Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.